Shenda Baker

Dr. Shenda Baker is an experienced entrepreneur and scientist with expertise in polymer physics, macromolecular and surface chemistry, and nanostructured materials. Dr. Baker served as CEO for Synspira, bringing the first Synedgen licensed technology into clinical trials for inhaled treatment for patients with cystic fibrosis. Dr. Baker was a professor of Chemistry at Harvey Mudd College from 1991-2014 with a research focus on polymer nanostructures and self-assembly at liquid and solid interfaces. She has held strategic positions on the Board of Directors of the Materials Research Society and has served on advisory boards with the National Institutes of Health at the National Institute for Dental and Cranofacial Research, National Science Foundation at the directorates of Maths and Physical Sciences, Computer and Information Science and Engineering, the Advisory Committee for CyberInfrastructure and at the Department of Energy. Dr. Baker is a member of the American Chemical Society and the Materials Research Society and currently serves on the Advisory Council of the National Institute of Dental and Craniofacial Research of the NIH. She is a co-inventor of all of the Synedgen technology.